Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1996-6-18
pubmed:abstractText
The inhibition of alpha i2-/- mouse cardiac isoproterenol-stimulated adenylyl cyclase (AC; EC 4.6.1.1) activity by carbachol and that of alpha i2-/- adipocyte AC by phenylisopropyladenosine (PIA), prostaglandin E2, and nicotinic acid were partially, but not completely, inhibited. While the inhibition of cardiac AC was affected in all alpha i2-/- animals tested, only 50% of the alpha i2-/- animals showed an impaired inhibition of adipocyte AC, indicative of a partial penetrance of this phenotype. In agreement with previous results, the data show that Gi2 mediates hormonal inhibition of AC and that Gi3 and/or Gi1 is capable of doing the same but with a lower efficacy. Disruption of the alpha i2 gene affected about equally the actions of all the receptors studied, indicating that none of them exhibits a striking specificity for one type of Gi over another and that receptors are likely to he selective rather than specific in their interaction with functionally homologous G proteins (e.g., Gi1, Gi2, Gi3). Western analysis of G protein subunit levels in simian virus 40-transformed primary embryonic fibroblasts from alpha i2+/+ and alpha i2-/- animals showed that alpha i2 accounts for about 50% of the immunopositive G protein alpha subunits and that loss of the alpha i2 is accompanied by a parallel reduction in G beta 35 and G beta 36 subunits and by a 30-50% increase in alpha i3. This suggests that G beta-gamma levels may be regulated passively through differential rates of turnover in their free vs. trimeric states. The existence of compensatory increase(s) in alpha i subunit expression raises the possibility that the lack of effect of a missing alpha i2 on AC inhibition in adipocytes of some alpha i2-/- animals may be the reflection of a more pronounced compensatory expression of alpha i3 and/or alpha i1.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1322501, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1330693, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1347957, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1354394, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-14169133, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1559993, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1560825, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1672265, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1679199, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1847995, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-1909362, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2113531, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2154370, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2175902, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2492452, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2506932, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2510151, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-2823384, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-3089781, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-3106786, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-3122662, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-3139455, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-4705382, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-6162842, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-6319385, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-6687224, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-7663509, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-8094261, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-8117295, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-8192647, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-8268981, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-8327893, http://linkedlifedata.com/resource/pubmed/commentcorrection/8622915-8335108
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3209-14
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2 alpha-/-mice.
pubmed:affiliation
Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.